Review Article Plastic Surgery
Does early mobilisation reduce time to diagnosis in adults with type 2 diabetes? A systematic review and meta-analysis

Does early mobilisation reduce time to diagnosis in adults with type 2 diabetes? A systematic review and meta-analysis

Authors

Adam Kim

Adam Kim

Cleveland Clinic Abu Dhabi, Peru

Corresponding

Published

August 13, 2026

Paper ID

PAP-000071

Status

Published

DOI

10.65712/tmj.test000329

Does early mobilisation reduce time to diagnosis in adults with type 2 diabetes? A systematic review and meta-analysis

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of time to diagnosis to health systems is substantial. Methods: Missing data were handled with multiple imputation. Results: The adjusted odds ratio was 0.58 (95% CI 0.43 to 0.75). Effects were consistent across prespecified subgroups. Conclusion: Residual confounding cannot be excluded.

Introduction

Practice around early mobilisation varies widely between centres. Earlier studies of early mobilisation were small or single-centre.

time to diagnosis remains a leading cause of avoidable harm among adults with type 2 diabetes. The cost of time to diagnosis to health systems is substantial.

Practice around early mobilisation varies widely between centres. time to diagnosis remains a leading cause of avoidable harm among adults with type 2 diabetes.

Materials and Methods

Eligible participants were adults with type 2 diabetes. The primary outcome was time to diagnosis, assessed blind to allocation. We conducted a systematic review and meta-analysis across 1 centres between 2015 and 2025.

Eligible participants were adults with type 2 diabetes. Analyses were adjusted for age, sex and baseline severity.

Results

Serious adverse events were rare and similar between groups. time to diagnosis occurred in 21% of the intervention group versus 19% of controls.

The adjusted odds ratio was 0.53 (95% CI 0.49 to 0.78). The adjusted odds ratio was 0.81 (95% CI 0.31 to 0.66).

Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.

GroupnEventsRate %OR95% CI
Control7323938.90.480.60–1.13
Intervention6346811.10.600.58–1.16
Age ≥ 65646897.00.770.43–1.28
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in time to diagnosis
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Trend in time to diagnosis
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.87 (95% CI 0.41 to 0.86). Effects were consistent across prespecified subgroups.

The adjusted odds ratio was 0.92 (95% CI 0.32 to 0.80). Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.

Discussion

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. These findings suggest that early mobilisation is associated with better time to diagnosis in adults with type 2 diabetes.

Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.

Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

Conclusions

Early mobilisation is a reasonable option for adults with type 2 diabetes to improve time to diagnosis.

References

1. Farouk K, Moreau Y, et al. Early mobilisation and patient satisfaction. Eur Heart J. 2010;62(11):277-1607.

2. Farouk A, Costa O, et al. SGLT2 inhibitors and surgical site infection. BMC Med. 2013;49(1):878-1318.

3. Mensah I, Mensah A, et al. Machine-learning triage and medication adherence. JAMA. 2023;182(9):702-1357.

4. Mensah Y, Moreau E, et al. Delayed cord clamping and time to diagnosis. N Engl J Med. 2024;192(1):65-1557.

5. Herrera K, Andersen A, et al. Continuous glucose monitoring and acute kidney injury. N Engl J Med. 2018;80(12):225-1791.

6. Ahmed U, Dubois B, et al. Tranexamic acid and medication adherence. JAMA. 2025;27(7):257-1498.

7. Tanaka E, Rossi M, et al. An antibiotic stewardship programme and falls. Crit Care Med. 2010;193(11):16-1490.

8. Andersen A, Volkov K, et al. Early enteral nutrition and falls. Pediatrics. 2016;155(1):75-1193.

Appendices

The statistical analysis plan is in the online supplement.